In vivo overexpression of IL-13 receptor α2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice

Journal of Experimental Medicine

Volumn 194, Issue 12, 2001, Pages 1743-1754

  Kawakami, Koji ^a   Kawakami, Mariko ^a   Snoy, Philip J ^b   Husain, Syed R ^a   Puri, Raj K ^a,b  

^a Lab of Tumor Immunology and Biology   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Cytokine receptor; IL 8; Neutrophil infiltration; Tumor antigen; Tumorigenesis

Indexed keywords

INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 8; TUMOR ANTIGEN;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; CORRELATION FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR REGRESSION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035905491     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.12.1743     Document Type: Article

References (50)

1. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses
2. Receptor for interleukin 13: Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9, and 15
3. Human ovarian carcinoma cell lines express IL-4 and IL-13 receptors: Comparison between IL-4- and IL-13-induced signal transduction
4. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor
5. c chain of the IL-2 receptor
6. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway
7. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors
8. cDNA cloning and characterization of the human interleukin 13 receptor α chain
9. Cloning and characterization of a binding subunit of the interleukin-13 receptor that is a component of the interleukin-4 receptor
10. Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex
11. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain
12. The murine IL-13 receptor α2: Molecular cloning, characterization, and comparison with murine IL-13 receptor α1
13. Structure of IL-13 receptor: Analysis of composition in cancer and immune cells
14. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft
15. IL-13 receptor α chain: A novel tumor associated transmembrane protein in primary explants of human malignant gliomas
16. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: Non-neoplastic glia and low-grade astrocytoma differ from malignant glioma
17. Interleukin-13 receptor α2 chain: An essential component for binding and internalization but not for IL-13 induced signal transduction through STAT6 pathway
18. Sensitization of cancer cells to interleukin 13-Pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor α chain
19. Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin-13 binding component IL-13 receptor α2 chain
20. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration
21. Interleukin 8 expression regulates tumorigenicity and metastasis in androgen-independent prostate cancer
22. Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13
23. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-α, IFN-γ, and TNF-α
24. An eosinophil-dependent mechanism for antitumor effect of interleukin-4
25. Murine interleukin-4 displays potent anti-tumor activity in vivo
26. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
27. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: A possible role for tumor progression
28. The chemokine system: Redundancy for robust outputs
29. Conversion of interleukin-13 into a high affinity agonist by a single amino acid substitution
30. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4
31. Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer
32. Interleukin-13 receptor α′ but not α chain: A functional component of interleukin-4 receptors
33. Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and -10 but not by interleukin-13
34. Expression of high affinity interleukin-4 receptors on human renal carcinoma cells and inhibition of tumor growth in vitro by interleukin-4
35. Ligand: A versatile computerized approach for characterization of ligand-binding systems
36. Expression of high affinity IL4 receptors on murine sarcoma cells and receptor mediated cytotoxicity of tumor cells to chimeric protein between IL-4 and Pseudomonas exotoxin
37. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells
38. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR)
39. Receptor for interleukin-13 on AIDS-associated Kaposi's sarcoma cells served as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein
40. Gene transfer of interleukin-13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts
41. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that induces leukocyte and fibroblast derived inflammatory agents, growth factors, and indicators of various activation processes
42. IL-4 production by human polymorphonuclear neutrophils
43. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes
44. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain
45. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13
46. Antitumor effect of locally produced CD95 ligand
47. Phenotypic and functional change of cytokine-activated neutrophils: Inflammatory neutrophils are heterogeneous and enhance adaptive immune responses
48. A soluble form or B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth
49. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis
50. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis